GL1X · GenesisL1 explorer

Research workbench

Crystal structure of abl kinase domain bound with a dfg-out inhibitor AP24534

Analyse Crystal structure of abl kinase domain bound with a dfg-out inhibitor AP24534 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3OXZ
Type
protein
Length
268 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase ABL1
EC
2.7.10.2
UniProt
P00520
Ligands
0LI
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase ABL1 (EC 2.7.10.2)protein26847% helix, 14% strandP00520

Ligands and binding sites

  • 0LI · 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl) phenyl}benzamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14570.740.83580LI
2570.450.8315empty

Compared structures

  • 3OXZ · Crystal structure of ABL kinase domain bound with a DFG-out inhibitor AP24534 · the same entry in another collection · chain A against A, TM-score 1.00
  • P00520 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase ABL1 (P00520) · a predicted model of the same protein · chain A against A, TM-score 0.90

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.